Â鶹ÊÓƵ

Â鶹ÊÓƵis deeply saddened by the passing of Dr. Timothy Beischlag, a respected scholar, educator and mentor, whose research, teaching and leadership left a lasting impact on students, colleagues and the broader scientific community. A founding member and professor in the Faculty of Health Sciences (FHS), he served with distinction for nearly two decades after joining Â鶹ÊÓƵin 2007. Beyond his contributions to FHS, Tim was a dedicated advocate for faculty colleagues across the university and served as President of the Â鶹ÊÓƵ Faculty Association (SFUFA) until September 2026.

At SFU, Dr. Beischlag built a research program dedicated to understanding how cells respond to environmental stressors, and how cancer cells adapt and spread, contributing to new therapeutic approaches. 

Dr. Beischlag's passing is a significant loss to the Â鶹ÊÓƵcommunity and to all who had the privilege of learning from, working alongside or being mentored by him. His legacy lives on through the students he inspired, the research he advanced and the many colleagues and collaborators whose lives he touched through his dedication, generosity and pursuit of knowledge.

Â鶹ÊÓƵextends its deepest condolences to Dr. Beischlag's family, friends, colleagues, students and all who mourn his loss. He will be remembered with gratitude and respect for his many contributions to research, teaching and the advancement of health sciences.

Research legacy

Dr. Beischlag's research legacy is defined by his pioneering work in molecular biology and cancer research, particularly his efforts to understand the mechanisms that drive cancer progression and metastasis. Throughout his career, he investigated how cells respond to environmental stressors such as low oxygen conditions (hypoxia) and environmental contaminants, helping to advance scientific understanding of the molecular pathways that influence disease development and human health. 

His most widely recognized contribution was the discovery of a cellular mechanism involving the retinoblastoma protein (Rb) that helps explain how primary tumour cells become more aggressive and acquire the ability to spread to other parts of the body. This work shed new light on the development of metastatic cancers, including prostate, breast, lung, neuroendocrine and brain cancers, and identified potential pathways for targeted therapies aimed at preventing or slowing the spread of disease.

Dr. Beischlag's research bridged fundamental science and real-world application. By uncovering key molecular drivers of metastasis, he helped lay the groundwork for new approaches to cancer treatment that could one day target cancer cells more precisely while reducing harm to healthy tissue. His findings, developed through collaborations with researchers at SFU, the University of British Columbia and the Vancouver Prostate Centre, continue to inform ongoing investigations into cancer biology and therapeutic development. 

Beyond his published discoveries, Dr. Beischlag leaves a lasting scholarly legacy through the graduate students, postdoctoral fellows and research trainees he mentored. His commitment to rigorous inquiry, collaboration and scientific excellence helped shape the careers of emerging researchers who continue to build upon the questions and discoveries that defined his work. Through both his scientific contributions and the people he inspired, his influence will continue to be felt across the fields of molecular biology, toxicology and cancer research for years to come.

Learn more about Dr. Beischlag’s research: Health Sciences Researcher Discovers Key To Why Primary Care Cancer Tumours Spread